Liposomal Delivery Enhances Short-Chain Ceramide-Induced Apoptosis of Breast Cancer Cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 468-475

  Stover, Tom ^a   Kester, Mark ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CASPASE 3; CASPASE 7; CATION; CERAMIDE; CERAMIDE DERIVATIVE; CHOLESTEROL; DIOLEOYL 1,2 DIACYL 3 TRIMETHYLAMMONIUM PROPANE; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DRUG VEHICLE; HEXANOYLSPHINGOSINE; LIPID; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYETHYLENEGLYCOL 450 C8 CERAMIDE; PROTEIN KINASE B; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL LEVEL; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MITOSIS INHIBITION; PHARMACOKINETICS; PRIORITY JOURNAL; SECOND MESSENGER; TARGET CELL; TRANSMISSION ELECTRON MICROSCOPY;

APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CERAMIDES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIPOSOMES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0142241305     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.054056     Document Type: Article

References (42)

1. Bai J and Pagano RE (1997) Measurement of spontaneous transfer and transbilayer movement of BODIPY-labeled lipids in lipid vesicles. Biochemistry 36:8840-8848.
2. Ballou LR, Chao CP, Holness MA, Barker SC, and Raghow R (1992) Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050.
3. Basu S and Kolesnick R (1998) Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 17:3277-3285.
4. Birbes H, Bawab SE, Obeid LM, and Hannun YA (2002) Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv Enzyme Regul 42:113-129.
5. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, and Kolesnick R (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
6. Bourbon NA, Sandirasegarane L, and Kester M (2002) Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 277:3286-3292.
7. Bourbon NA, Yun J, Berkey D, Wang Y, and Kester M (2001) Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions. Am J Physiol Cell Physiol 280: C1403-C1411.
8. Bruno AP, Laurent G, Averbeck D, Demur C, Bonnet J, Bettaieb A, Levade T, and Jaffrezou JP (1998) Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ 5:172-182.
9. Chang Y, Abe A, and Shayman JA (1995) Ceramide formation during heat shock: a potential mediator of alpha B-crystallin transcription. Proc Natl Acad Sci USA 92:12275-12279.
10. Charles R, Sandirasegarane L, Yun J, Bourbon N, Wilson R, Rothstein RP, Levison SW, and Kester M (2000) Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res 87:282-288.
11. Dbaibo GS, Obeid LM, and Hannun YA (1993) Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J Biol Chem 268:17762-17766.
12. Furuya K, Ginis I, Takeda H, Chen Y, and Hallenbeck JM (2001) Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 21:226-232.
13. Gulbins E and Kolesnick R (2002) Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell Biochem 36:229-244.
14. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, and Kolesnick RN (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525-535.
15. Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128.
16. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science (Wash DC) 274:1855-1859.
17. Holopainen JM, Lehtonen JY, and Kinnunen PK (1997) Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Chem Phys Lipids 88:1-13.
18. Holopainen JM, Subramanian M, and Kinnunen PK (1998) Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/ sphingomyelin membrane. Biochemistry 37:17562-17570.
19. Ito A and Horigome K (1995) Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65:463-466.
20. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, and Grant S (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77.
21. Ji L, Zhang G, Uematsu S, Akahori Y, and Hirabayashi Y (1995) Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 358:211-214.
22. Johns DG, Charpie JR, and Webb RC (1998) Is ceramide signaling a target for vascular therapeutic intervention? Curr Pharm Des 4:481-488.
23. Kolesnick RN and Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665.
24. Kundu N and Fulton A (2002) Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res 62:2343-2346.
25. Lucci A, Han TY, Liu YY, Giuliano AE, and Cabot MC (1999) Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells. Cancer 86:300-311.
26. Maurer BJ, Melton L, Billups C, Cabot MC, and Reynolds CP (2000) Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J Natl Cancer Inst 92:1897-1909.
27. McEarchern J, Kobie JJ, Mack V, Wu RS, Meade-Tollin L, Arteaga CL, Dumont N, Besselsen D, Seftor E, Hendrix MJC, et al. (2001) Invasion and metastasis of a mammary tumor involves TGF-β signaling. Int J Cancer 91:76-82.
28. Mehta S, Blackinton D, Omar I, Kouttab N, Myrick D, Klostergaard J, and Wanebo H (2000) Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol 46:85-92.
29. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, and Wang E (1997) Sphingolipids - the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol 142:208-225.
30. Pagano RE and Martin OC (1988) A series of fluorescent N-acylsphingosines: synthesis, physical properties and studies in cultured cells. Biochemistry 27:4439-4445.
31. Radin NS (2001) Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur J Biochem 268:193-204.
32. Reddy KR (2000) Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother 34:915-923.
33. Simon CG Jr, Holloway PW, and Gear AR (1999) Exchange of C(16)-ceramide between phospholipid vesicles. Biochemistry 38:14676-14682.
34. Spiegel S and Merrill AH Jr (1996) Sphingolipid metabolism and cell growth regulation. FASEB J 10:1388-1397.
35. Strum JC, Small GW, Pauig SB, and Daniel LW (1994) 1-beta-D-arabinofuranosyl-cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:15493-15497.
36. Tepper AD, de Vries E, van Blitterswijk WJ, and Borst J (1999) Ordering of ceramide formation, caspase activation and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J Clin Investig 103:971-978.
37. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun YA, and Seldin MF (1995) Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 92:8443-8447.
38. Van Blitterswijk WJ, Van Der Luit AH, Veldman RJ, Verheij M, and Borst J (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369:199-211.
39. Veiga MP, Arrondo JL, Goni FM, and Alonso A (1999) Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys J 76:342-350.
40. Venkataraman K and Futerman AH (2000) Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol 10:408-412.
41. Webb MS, Saxon D, Wong FM, Lim HJ, Wang Z, Bally MB, Choi LS, Cullis PR, and Mayer LD (1998) Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta 1372:272-282.
42. Zhou H, Summers SA, Birnbaum MJ, and Pittman RN (1998) Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568-16575.